Results 161 to 170 of about 118,448 (336)

Behavioral studies of the effects of dopamine and 5-HT1A agonists in cynomolgus monkeys

, 1989
Eiji Mizuta, Motonori Yamaguchi, Sadako Kuno   +2 more
openalex   +1 more source

The Impact of Deep Brain Stimulation of the Subthalamic Nucleus on Sleep–Wake Function and Circadian Rhythms in Patients with Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well‐established therapy in advanced Parkinson's disease (PD) improving motor and non‐motor signs including sleep. The mechanisms of sleep improvement are insufficiently understood.
Julia Steinhardt, Laura Lokowandt, Cosima Xenia Schmidt, Dirk Rasche, Henrik Oster, Britta Wilms, Norbert Brüggemann   +6 more
wiley   +1 more source

¹¹C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy. [PDF]

Pituitary, 2022
Bashari WA, van der Meulen M, MacFarlane J, Gillett D, Senanayake R, Serban L, Powlson AS, Brooke AM, Scoffings DJ, Jones J, O'Donovan DG, Tysome J, Santarius T, Donnelly N, Boros I, Aigbirhio F, Jefferies S, Cheow HK, Mendichovszky IA, Kolias AG, Mannion R, Koulouri O, Gurnell M.   +22 more
europepmc   +1 more source

A Real‐World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is a neurodegenerative disorder associated with motor and nonmotor symptoms. Objectives This study assesses levodopa dose management, the therapeutic goals of clinicians, the factors that influence clinicians' choice of therapy, and the role of nonmotor symptoms using real‐world evidence from Germany, Italy,
Fabrizio Stocchi, Jaime Kulisevsky, Wolfgang H. Jost   +2 more
wiley   +1 more source

Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model

Neurobiology of Disease, 2004
Brain cannabinoid CB1 receptors are expressed in neural areas that contribute to movement such as basal ganglia, where they co-localize with dopamine D1 and D2 receptors.
Fadwa El Banoua, Isabel Caraballo, Juan A Flores, Beatriz Galan-Rodriguez, Emilio Fernandez-Espejo   +4 more
doaj  

Super-stereotypy II: Enhancement of a complex movement sequence by intraventricular dopamine D1 agonists [PDF]

, 2000
Kent Berridge, J. Wayne Aldridge
openalex   +1 more source

Observed and Patient‐Perceived Information Provision When Diagnosed With Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background People with Parkinson's disease (PD) perceive to receive insufficient disease‐specific information after diagnosis, whereas clinicians report providing all relevant information. Objectives The objectives were to examine the information actually provided by clinicians during diagnostic consultations and its relations with background ...
Elisabeth Kurpershoek, Marij A. Hillen, Mark H.B. Huisman, Machiel Pleizier, Annemarie Vlaar, Jeroen Blankevoort, Evelien Zoons, Dareia Selina Roos, Marianne de Visser, Rob M.A. de Bie, Joke M. Dijk   +10 more
wiley   +1 more source

Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in mice

Neurobiology of Disease, 2006
Genetic and biochemical abnormalities associated with α-synuclein are implicated in the etiology of Parkinson's disease (PD). In this study, altered locomotor behavior linked to the expression of mutant or wildtype human α-synuclein was investigated ...
Erica L. Unger, David J. Eve, Xiomara A. Perez, Dawn K. Reichenbach, Yanqun Xu, Michael K. Lee, Anne M. Andrews   +6 more
doaj  

Influence of Selective Dopamine Agonist Ropinirole on Conditioned Place Preference and Somatic Signs of Morphine Withdrawal in Rats. [PDF]

Front Behav Neurosci, 2022
Shahzadi A, Shahzadi A, Yunusoglu O, Karabulut E, Sonmez H, Yazici Z.   +5 more
europepmc   +1 more source

Effects of intravenous injection of dopamine D2 receptor agonists on striatal neurons of rats.

, 1993
Hiroaki Matsubayashi, Taku Amano, Masashi Sasa   +2 more
openalex   +1 more source